Radioguided surgery using gamma probes is considered an established discipline that has revolutionized the surgical treatment of different types of cancer. In view of this, and given the importance of having a more precise probe, intramephal imaging has developed a probe with greater sensitivity for the detection of cancer-related anomalies.
How it works
This gamma probe, which connects via Bluetooth to a device that displays all the information, aims to improve the sensitivity with respect to the probes currently available in the market. This would considerably increase surgical certainty in procedures where it is difficult to differentiate the location of either a tumor or a lymph node for a subsequent biopsy.
Clinical trials of this equipment have been carried out on patients with breast cancer or tumors in other areas of the body. After the surgeries, the results have been positive, i.e. there is a record of a higher rate of radioactive activity detected by the probe for the same dose of radiopharmaceutical, but this can still be improved.
This instrument for surgeries already exists within the medical equipment market, but the great difference that we propose from Intramedical Imaging, together with the whole team of doctors and engineers, is to use a totally different electronics and configuration to those currently offered, in order to have a system of greater sensitivity and easy handling.
Both the sensor and the electronics have never before been used in gamma probes. Our equipment makes use of the latest technology in crystals and light sensors, which allows to considerably increase the sensitivity of the probe to perform less invasive surgeries, with greater precision and hypothetically could lower the doses of radiopharmaceuticals, avoiding complications during or after the operation.
Gamma probe for cancer detection
The main uses are for operations to remove cancerous tissue from any part of the body. The operation of such interventions consists of a previous injection of a radiopharmaceutical that concentrates in the cancerous cells. Then, with the probe, the areas with the highest levels of radioactivity are identified for their subsequent removal.
Is there any risk?
Other instruments on the market are not sufficiently reliable, since sometimes there is a high rate of radioactive background noise that does not allow the tumor or lymph node to be correctly identified. In addition to exposing the patient to dangerous chemicals.
This can mean that the doctor, by removing good tissue or - on the other hand - can leave cancerous tissue in the body, a risk that our probe wants to reduce to zero.
That is why we invite you to check out our online store - www.intramedicalimaging.com/products - and review all the equipment we have designed over the last 20 years. At Intramedical Imaging we are at the forefront of nuclear medicine.